Omar
@dromar.eth
Wouldn’t be surprised to see many GLP-1 based economies struggle after May 21st once compounding goes away. This includes many ‘Longevity’ companies whose main source of revenue are compounded GLP-1 meds.
1 reply
2 recasts
4 reactions
Kasra Rahjerdi
@jc4p
wait what’s happening may 21, i thought they were already sketchy bc of the shortage being officially over?
1 reply
0 recast
1 reaction
Omar
@dromar.eth
Yup? Tirzepatide was already banned, but May 21 is when compounded semaglutide will be off the list so has to be ceased production. Most compounding clinics use semaglutide as it’s cheaper and had a more widespread economy (B12+semaglutide), (rapamycin+semaglutide), (nlrp3 + semaglutide) in the longevity community.
1 reply
0 recast
1 reaction
Omar
@dromar.eth
Sorry ignore the exclamation. I still can’t use the iPhone keyboard.
1 reply
0 recast
1 reaction
Kasra Rahjerdi
@jc4p
ahhh got it, i’ve had to go from saxenda during the ozempic shortage to mounjaro shortage to zepbound to compound with b12 and glycine, been a journey!! 😂
1 reply
0 recast
1 reaction
Kasra Rahjerdi
@jc4p
i (of course) want to try retatrutide now 🙈
1 reply
0 recast
1 reaction
Omar
@dromar.eth
Oh wow! Thats quite a journey! 😂 retatrutide looks to be solid. Though I think the recent phase 3 showed around 26% annual weigh my loss vs Zepbounds 20%. Btw if zepbound worked well for you, then Lilly has zepbound vials for $499 now that’s the best weight loss/cost ratio. Not as good as compounded tho
1 reply
0 recast
1 reaction
